Slide background

Forum Format

The forum combines high-level plenary presentation and panel platforms in addition to interactive group discussions. Overarching themes for the forum include, but are not limited to: 

  •     Investor engagement, education and communication
  •     Strategies on fundraising and raising capital
  •     M&A strategy
  •     Strategies to cultivate a strong general environment for life science investment
  • •  Areas of collaboration between CEOs and CFOs 

FORUM AGENDA

8:30 Registration and coffee
PLENARY KEYNOTES
9:25 Welcome remarksNeil Darkes and Terry O’Dwyer, Co-CEO’s, Biotech and Money
9:30 Keynote: 2015/2016 Life Science and Healthcare Market OutlookDavid MacMurchy, Partner, Consumer Products, Retail and Life Science Leader and Head of Life Sciences, EY
9:50 Keynote: Capital Market Perspectives: addressing the imbalance between the UK and USGil Bar-Nahum, Managing Director, Global Healthcare Investment Banking, Jefferies and Co.
10:10 Keynote: Evolution of tapping public marketsNelson Griggs, EVP, Listings, Nasdaq
10:30 Coffee and networking
DISCUSSION GROUPS
11:00 Strategies on fundraising and raising capital ·       Where and how to raise funds for development projects: In the very early stages, and when market sentiment is low

·       Where and how to target investors: retail vs institutional vs specialist

·       What strategies work best and why?

·       Going global: advantages and challenges of dual listings

Group 1: Gil Bar-Nahum, Managing Director, Global Healthcare Investment Banking, Jefferies and Co.

Group 2: Bob McCooey, Senior Vice President, Global Relationship Management, Nasdaq

12:30 Seated networking luncheon
DISCUSSION GROUPS
13:30 How and where will you grow?·        When should growth be organic or inorganic?

·        How should current trends in deal structures, M&A and licensing inform your strategy?

·        Moving into new markets vs expanding your share in existing markets

·        Mergers & Acquisitions: strategies to acquiring or being acquired

·        How to reconcile relative valuations?

·        What should CEO’s focus on when searching for collaborations or partnerships?

Group 1: Jamie Heath, Head of Life Sciences Transaction Advisory, Europe, Middle East, Africa and India, EY

Group 2: David MacMurchy, Partner, Consumer Products, Retail and Life Science Leader and Head of Life Sciences, EY

15:00 Coffee and Networking
DISCUSSION GROUPS
15:30 Investor Engagement, Education and Communication·       How can the industry better educate and engage with generalist investors?

-        Communications strategy: how to deliver the message

-        Understanding what investors are looking for and why

·       How to engage with specialist investors? What strategies work best and why?

·       How should CEOs and CFOs work with retail investors?

·       Communication: placements & capital raising, M&A communication and continuous financial communication and IR

Group 1: Melanie Toyne-Sewell, Partner, Instinctif Partners

Group 2: Mary Clark, Managing Director, International Healthcare, Hume Brophy

DISCUSSION THEATRE
16:30 How to improve investor appetite for the sector ·       How can CEO’s better collectively influence healthcare investment appetite?

·       Strategies to cultivate a strong climate and environment ripe for investment;

·       Developing and cultivating entrepreneurs and talent

·       Areas of collaboration between CEOs and CFOs

·       How to celebrate success stories and communicate them

·       What tangible actions can be made?

John Hodgson, Data Editor, Scrip

17:30 Action points and Wrap Up
17:40 Drinks Reception

  • Biotech and Money Ltd The Euston Office One Euston Square 40 Melton St
    London , NW1 2FD
  • Monday  -  Monday

    Monday -  Monday

Cornerstone Partners

Slide background